We have shown before that KCa3.1 channel activity is lower in CD8+ cells isolated from head and neck cancer (HNC) patients’ blood: it could be attributed to the reduced calmodulin expression or inhibition of adenosine through adenosine receptor A2A [13,19,24,25]. The gene discussed is CD8A; the disease is head and neck cancer.